Literature DB >> 17714399

The Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar Typhimurium.

D Fayol-Messaoudi1, M-H Coconnier-Polter, V Lievin-Le Moal, F Atassi, C N Berger, A L Servin.   

Abstract

AIMS: The purpose of this study was to investigate the antibacterial activity of the Xynotyri cheese isolate Lactobacillus plantarum ACA-DC287 using a set of in vitro and in vivo assays. METHODS AND
RESULTS: The co-culture of L. plantarum strain ACA-DC287 and Salmonella enterica serovar Typhimurium strain SL1344 results in the killing of the pathogen. The killing activity was produced mainly by non-lactic acid molecule(s) that were present in the cell-free culture supernatant of the L. plantarum strain ACA-DC287. The culture of the L. plantarum strain ACA-DC287 inhibited the penetration of S. typhimurium SL1344 into cultured human enterocyte-like Caco-2/TC7 cells. In conventional mice infected with S. typhimurium SL1344, the intake of L. plantarum strain ACA-DC287 results in a decrease in the levels of Salmonella associated with intestinal tissues or those present in the intestinal contents. In germ-free mice, the L. plantarum strain ACA-DC287 colonized the gastrointestinal tract.
CONCLUSIONS: The L. plantarum strain ACA-DC287 strain exerts anti-Salmonella activity similar that of the established probiotic strains Lactobacillus rhamnosus GG, Lactobacillus casei Shirota YIT9029 and Lactobacillus johnsonii La1. SIGNIFICANCE AND IMPACT OF THE STUDY: The observation that a selected cheese Lactobacillus strain exerted antibacterial activity that was similar to those of probiotic Lactobacillus strains, is of interest for the use of this strain as an adjunct strain for the production of health-giving cheeses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714399     DOI: 10.1111/j.1365-2672.2007.03293.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

1.  Impairment of swimming motility by antidiarrheic Lactobacillus acidophilus strain LB retards internalization of Salmonella enterica serovar Typhimurium within human enterocyte-like cells.

Authors:  Vanessa Liévin-Le Moal; Raymonde Amsellem; Alain L Servin
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

Review 2.  Peanut Butter Food Safety Concerns-Prevalence, Mitigation and Control of Salmonella spp., and Aflatoxins in Peanut Butter.

Authors:  Tapiwa Reward Sithole; Yu-Xiang Ma; Zhao Qin; Xue-De Wang; Hua-Min Liu
Journal:  Foods       Date:  2022-06-24

Review 3.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

4.  Core Fucosylation of Intestinal Epithelial Cells Protects Against Salmonella Typhi Infection via Up-Regulating the Biological Antagonism of Intestinal Microbiota.

Authors:  Sijia Hao; Qingjie Fan; Yaqiang Bai; Hui Fang; Jiaorui Zhou; Tomohiko Fukuda; Jianguo Gu; Ming Li; Wenzhe Li
Journal:  Front Microbiol       Date:  2020-05-27       Impact factor: 5.640

5.  Identification and Characterization of Malolactic Bacteria Isolated from the Eastern Foothills of Helan Mountain in China.

Authors:  Jingxian Sun; Yuzi Ge; Xiaobo Gu; Ruyi Li; Wen Ma; Gang Jin
Journal:  Foods       Date:  2022-08-15

6.  Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion.

Authors:  Raffaella Campana; Saskia van Hemert; Wally Baffone
Journal:  Gut Pathog       Date:  2017-03-06       Impact factor: 4.181

7.  Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria.

Authors:  Winschau F van Zyl; Shelly M Deane; Leon M T Dicks
Journal:  Gut Microbes       Date:  2020-11-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.